Responsive Neurostimulation (RNS) of the Centromedian Nucleus (CMN) of the Thalamus for the Treatment of Drug Resistant Idiopathic Generalized Epilepsy (IGE)

Files

Authors

Angelique Manasseh, Beaumont Health Resident
Hannah Guider, Beaumont Health Resident
Brooklynn Bondy, Beaumont Health Resident
Sanjay Patra, Corewell Health West
David Burdette, Corewell Health West
Ayman Haykal, Corewell Health West
Nour Baki, Beaumont Health
Ashleigh Terrell, Beaumont Health
Michael Staudt, Beaumont Health
Christopher Parres, Beaumont Health
Andrew Zillgitt, Beaumont Health

Description

Idiopathic generalized epilepsy (IGE) accounts for nearly 1/3 of all epilepsies1

▪ Approximately 20-30% of people with IGE are refractory to adequate anti-seizure medication trials1

▪ RNS implantation is a unique closed-loop neuromodulation therapy, and case reports as well as case series have demonstrated improved seizure control in patients with drug resistant IGE1

▪ More recently, targeting the centromedian nucleus of the thalamus with RNS has been explored as a potential surgical treatment option for patients with drug resistant IGE

Publication Date

5-4-2023

Disciplines

Neurology | Neurosurgery | Nursing

Recommended Citation

Manasseh A, Guider H, Bondy B, Patra S, Burdette D, Haykal A, et al [Baki N, Terrell A, Staudt M, Parres C, Zillgitt A] Responsive neurostimulation (rns) of the centromedian nucleus (cmn) of the thalamus for the treatment of drug resistant idiopathic generalized epilepsy (ige). Presented at Beaumont Hospital Farmington Hills 2023 Alvin Yarrows Research Day; 2023 May 4; Farmington Hills, MI.

Comments

2023 Alvin Yarrows Research Day at Beaumont Hospital Farmington Hills, Farmington Hills, MI, May 4, 2023.